Jun. 10 at 11:04 AM
$VNDA
The Home Run for the
$VNDA BO may very well be Tradipiant for GLP-1 nausea ….
$PFE &
$LLY have a great need for this drug ALONG with BYSANTI …
The SUPER-HUGE market for tradipitant will be the
$15 BILLION GLP-1 nausea market today, which is projected at GROWING to
$45-
$60 BILLION by 2030!!! That is why a GL-1 Pharma will do a buyout soon !! …..
It will end up being a blockbuster drug against GLP-1 nausea …
top-line results from a Phase II study indicated that Vandas’ tradipitant was effective at reducing vomiting and nausea caused by GLP-1 receptor agonists like Wegovy in adults …
FOLLOW me 👉 @Mike22332233 for latest info
AND, nobody is thinking of this .... ALMOST ALL Cancer Chemo/Drugs have some amount of nausea associated with them .... AND HOLD STEADY as I tell you the market size here ....
In 2025, worldwide spending on oncology medicines (at list prices) reached
$252 billion and is projected to potentially reach nearly
$700 billion by 2034 ....
